Skip to content

Exploration of clinical efficacy and imaging results of super strong cruciate ligament reconstruction after anterior cruciate ligament reconstruction: a randomized controlled clinical trial

Exploration of clinical efficacy and imaging results of super strong cruciate ligament reconstruction after anterior cruciate ligament reconstruction: a randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100822
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior cruciate ligament rupture

Interventions

Experimental group:Adopting super strong ACL reconstruction technology
Traditional group:Adopting traditional ACL reconstruction techniques

Sponsors

Lishui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age 16~45 years old; 2. MRI of the knee joint showed ACL rupture; 3. Tendon autologous transplantation; 4. The meniscus combined injury treated during the operation does not affect the standard postoperative rehabilitation plan; 5. Intraoperative cartilage injury is grade III or below, which does not affect the standard postoperative rehabilitation plan; 6. At least 12 months of follow-up;

Exclusion criteria

Exclusion criteria: 1. Age 45 years old; 2. Have a history of previous ACL or bilateral ACL injury and knee surgery; 3. MRI showing fracture, PCL, medial collateral ligament or LCL injury; 4. Grade IV cartilage injury or unstable longitudinal meniscal tear requiring repair that interferes with the standard rehabilitation protocol after surgical treatment; 5. Not meeting the requirements for 12-month follow-up; 6. Patients with serious underlying diseases, unsuitable for surgery, psychiatric illness, pregnancy during the planned trial, or other diseases that are not conducive to long-term follow-up.

Design outcomes

Primary

MeasureTime frame
International Knee Documentation Committee (IKDC) Score;

Secondary

MeasureTime frame
Knee joint injury and osteoarthritis outcome score (KOOS score);Visual Analog Pain Scale (VAS) score;Lysholm score;Transplant diameter;Operative time;Imaging evaluation;

Countries

China

Contacts

Public ContactBo Wang

Lishui People's Hospital

bowang3332@lsu.edu.cn+86 189 5709 3332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026